September 20th 2024
Peptides are increasingly used in cosmeceuticals for their ability to enhance cellular communication and functionality in antiaging formulations.
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Amino acid accelerates wound repair
August 1st 2002Chicago - Treatment of chronic wounds, such as skin ulcers associated with aging or diabetic skin, represents an unmet medical need. Thymosin b4 (Tb4) shows promise as a therapeutic agent for wound repair in aging and diabetic patients, according to Allan L. Goldstein, Ph.D., who spoke at the annual International Symposium on Aging Skin.
Use of fillers in dark skin has nuances
August 1st 2002New York -While the use of fillers in skin of color does not differ too much from the use of fillers in people with lighter skin, there are a couple of very important points for dermatologists to consider, Derek H. Jones, M.D., said at the annual meeting of The Skin of Color Center, St. Luke's Roosevelt Hospital Center, New York.
Sunscreens evolve to broad-spectrum filtering systems
August 1st 2002New Orleans - Tremendous progress in photobiology research has led to a better understanding of skin mechanisms, permitting the development of effective sunscreens, Michele Verschoore, M.D., reported at the annual meeting of the American Academy of Dermatology.
CO2 laser accepted for blepharoplasty
July 1st 2002Orlando, Fla. Wide acceptance of blepharoplasty performedwith a carbon dioxide laser is due to the instrument's ability to allowthe surgeon to incise tissue in an almost bloodless fashion, coagulate vessels,and ablate fat without clamping, David T. Harvey, M.D., F.A.A.D., F.A.C.P.,said at the Florida Society of Dermatologic Surgeons meeting.
Excimer laser repigments facial scars
July 1st 2002Atlanta - Two recent studies suggest that the 308nm excimer laser may be the first device effective in the treatment of hypopigmented facial scars, striae, and hypopigmentation caused by resurfacing with the CO2 laser. Both studies were presented at the 22nd annual meeting of the American Society for Laser Medicine and Surgery.
Levels of sedation require derm surgeons' adherence
July 1st 2002New Orleans - Sedating patients is a serious business, and dermatologic surgeons need to be well aware of the progressive levels of sedation and ensure that patients are monitored appropriately to prevent complications, J. Lance Lichtor, M.D., said.
Buyer's remorse? Older the tattoo, the better
July 1st 2002Atlanta - Older tattoos are removed faster and more completely after laser treatment compared with newer tattoos, according to the results of a preliminary study presented by Erick A. Mafong, M.D., at the annual meeting of the American Society for Laser Medicine and Surgery.
Nd:YAG use expanded to facial telangiectasias
July 1st 2002Atlanta - Physicians may be able to expand the uses of the 1064nm Nd:YAG laser, used to treat telangiectasias and small reticular veins in the lower extremities, by also applying it to the treatment of facial telangiectasias, said David J. Goldberg, M.D., J.D., director, Skin & Laser Surgery Specialists of New York and New Jersey.
Radiofrequency device offers advantages of its own
July 1st 2002Atlanta - A new radiofrequency energy device that can nonablatively change the morphology of the dermis and allow the physician to put a high amount of energy into the skin is a huge step forward in the treatment of cosmetic conditions, said Karl Pope, director of research, Thermage, Hayward, Calif. Thermage is developing an RF device for treatment of skin in dermatology and plastic surgery applications.
Arachnophlebectomy needle proves effective for leg telangiectasias
June 1st 2002Las Vegas - Destruction of veins by a sharp-tipped needle maybe a more effective approach to leg telangiectasias than sclerotherapy,according to Linda Woodson, M.D. She views this new modality as an appropriatestrategy for sites that have been resistant to sclerotherapy, rather thanas a first-line therapy.
Shoe-related CD sometimes hard to size up
June 1st 2002Maui, Hawaii - Shoe-related allergic contact dermatitis is commonlyoverlooked in the differential diagnosis of foot dermatitis, mainly becausepatients are not patch tested, according to James S. Taylor, M.D. at theSkin Disease Education Foundation's 26th Hawaii Dermatology Seminar.
Patients still having too much
June 1st 2002For more than a decade and a half, dermatologists have been stronglyadvocating the use of sunscreens and urging people to avoid sun exposure- yet skin cancer is still the most common cancer in the United States.It affects about a million Americans every year and is responsible for about2 percent of all cancer deaths, with melanoma accounting for about three-quartersof all skin cancer deaths.
Tanning beds, acitretin equal psoriasis clearing
June 1st 2002New Orleans - A small study combining commercial tanning bed therapy and acitretin has provided big results for patients with moderate to severe plaque-type psoriasis. In addition to rapid clearance of skin disease, the treatment is far more accessible for most patients and much less expensive than more traditional forms of light therapy,